Category: 
October 23, 2007
One of the key factors insurance companies use in determining insurance premiums is whether or not we smoke and, in some cases, whether or not we use tobacco in any form. The U. S. Food and Drug Administration (FDA), in 2006, approved a new “Stop Smoking” drug called Chantix which is the name under which this drug is marketed and distributed by its manufacturer, Pfizer Inc. The drugs actual name is varenicline tartrate.
|
|
|
The Centers for Disease Control (CDC) estimates that there are approximately 45 million adult (over age 18) cigarette smokers in the United States. The real surprising part is that 8 million or more of them have at least one serious illness caused by smoking.
Dr. Scott Gottlieb, FDA’s Deputy Commissioner for Medical and Scientific Affairs, states - “Tobacco use, particularly cigarette smoking, is the single most preventable cause of death in the United States and is responsible for a growing list of cancers as well as chronic diseases including those of the lung and heart.” Advertisements on TV tell us that Chantix will help us stop smoking in “12 weeks”, maybe or maybe not. No prescription medication should be taken without first consulting your personal physician. If you and your doctor think Chantix is right for you, then maybe this new drug can reduce your risk of a serious illness and at the same time make buying insurance a more pleasant experience by making your insurance premiums much less. Please understand this article is not an endorsement for Chantix. For more information on Chantix and other prescription drugs which are supposed to help stop the smoking habit, please visit:
|
Buying Insurance
Insurance Terms
|
Insurance Contact Information In The United States
Sorry, comments are closed.